All Natural FMG, Inc., Announces Its Topical Solution to Oral NSAIDs [Celebrex/Vioxx/Bextra]: IbuCream tm

Topical ibuprofen avoids problems associated with oral pain medications.

Hollywod, FL (PRWEB) December 20, 2004 -- Developed over 8 years ago and supported with pre-clinical feedback by over 4,000 patients, IbuCream tm is an emulsion containing 10 % ibuprofen and 1% lidocaine. Apparent benefits are the by-passing of the stomach, small intestines and liver as well as using less than the oral dose of 200 mg ibuprofen when IbuCream tm is applied directly to the site of pain. General patient feedback points to rapid onset of pain relief that can last up to 4 hours or longer.

IbuCream tm is delivered through the skin via a patent pending emulsion, ViaDerm FMG: Serial # 10/412,626 -- Alcohol-free transdermal analgesic composition and process for manufacture and use thereof." IbuCream tm is available by prescription only at Post Haste Pharmacy in Hollywood.

ViaDerm FMG can be used for topical delivery of pharmaceutical and cosmetic actives. It can also be formulated into creams, gels, sprays, intranasal solutions, and patches. The delivery system has demonstrated efficacy in delivery of agents for pain management, hormone replacement, weight management, insulin delivery, and erectile dysfunction.

All Natural FMG, Inc. also owns patent-pending Serial # 10/412,637 -- Alcohol-free transdermal insulin composition and processes for manufacture and use thereof." Both patents are scheduled to be granted in Spring of 2005.

All Natural FMG, Inc. is negotiating with a South Florida University to conduct clinical studies re safety and effectiveness of IbuCream tm, and it seeks investors who want to participate in furthering the applications of ViaDerm FMG with RX-to-OTC drugs.

###